As winter approaches, trader Todd Gordon thinks natural gas is headed toward a “potential technical breakout.” » Read More
Several ETFs may benefit more than others following the Fed's decision on Wednesday.
The Fed left rates unchanged, and one strategist believes that now's the time to buy stocks.
Todd Gordon of TradingAnalysis.com is betting against CVS.
Now that the S&P 500 has cooled off a bit, one technical analyst calls the key levels he is watching right now.
The market could see a spike in volatility before the end of the year, according to one strategist.
Learn how to fully take advantage of a strategy that may help you swap profit potential for the opportunity to reduce risk.
Most aren't expecting the Fed to raise rates on Wednesday, but if it does, these stocks could get hit hardest.
The financials is the only S&P 500 sector down on the year. Here's why it could soon get even worse — no matter what the Federal Reserve announces.
Even though GoPro shares have cratered over the past year, trader Todd Gordon thinks the company is set to rally into the holiday season.
The market is not adequately pricing in the likelihood of a Donald Trump victory, according to one strategist.
One strategist predicts a market plunge should the Fed raise rates, and it has to do with global factors.
Stocks tend to slide in the 38th week of a year. Will they do so in 2016?
Apple's shares are slipping on Monday, but trader Todd Gordon sees a big opportunity to make money on the tech giant's next move.
There's a 50 percent chance that a market correction is ahead, says one portfolio manager, and investors should be prepared.
History suggests the rally will continue, according to perennial bull Tom Lee. That means the S&P's recent dip "needs to be bought aggressively."
One trader has made a $1 million bet against the gold mining stocks.
Stacey Gilbert, Susquehanna Capital Group Market Strategist, and Boris Schlossberg, BK Asset Management Managing Director of FX Strategy, discuss the luxury retail sector with Brian Sullivan.
Rich Ross, Evercore ISI, and Max Wolff, Manhattan Venture Partners, discuss the moves in the biotech sector with Brian Sullivan.
Craig Johnson, Piper Jaffray Senior Technical Strategist, and Zachary Karabell, Envestnet Head of Global Strategy, discuss their outlooks for the S&P 500 under the shadow of the Fed with Melissa Lee.